chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Sore arm after both doses Covid-19 vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 33 year-old male patient received bnt162b2 (BNT162B2), administered in arm left (Batch/Lot number: unknown) as dose 1, single and administered in arm left, administration date 02May2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "Seizures" (unspecified if ongoing); "Bowel obstruction", start date: 2017 (unspecified if ongoing); "sinus tach" (unspecified if ongoing); "Depression" (unspecified if ongoing); "Anxiety" (unspecified if ongoing); "high blood pressure readings" (unspecified if ongoing); "Pneumonia" (unspecified if ongoing); "G-tube" (unspecified if ongoing); "Fast heart rate" (unspecified if ongoing). Concomitant medication(s) included: ONFI taken for seizure, start date: 2018 (ongoing); METOPROLOL taken for heart rate increased, sinus tachycardia, start date: 2014 (ongoing). The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "recovered", described as "Sore arm after both doses Covid-19 vaccine". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of pain in extremity. No follow-up attempts are possible. No further information is expected.
In March & April of 1999, pt rcv'd injections of Lymerix.He exp debilitating pain which required him to use crutches. He also began to exp arthritic & neurologic symptoms. Allegedly, after 14 dr & no dx reached the pt committed suicide. Autopsy shows final diagnosis of heart, left ventricular hypertrophy, aortic atherosclerosis, lung congestion, pancreas, autolysis, depression, committed suicide by hanging.
- Slightly elevated temperature of 99.9 degrees F - Diarrhea - Nausea - Chills - Headache - Soreness at vaccine site - Dizziness
Within 30 minutes of getting the shot I had intense pain in my left arm.  My elbow hurt so much i couldn't even buckle myself in the car.  Shooting pain down arm from elbow to wrist.  Swollen gland for weeks.  These were seen as reactions that do happen.  The arm weakness and pain continued, although it would go away at times.  If I used my left arm or carried anything over a lb, the pain came back.  Upon receiving my 3rd dose the DR asked me about my reaction to second dose and told me it was nerve pain.  Asked if my shot was given high on my arm, yes it was very high almost shoulder and he told me this was most likely nerve damage.  On 2/7/22 I used my left arm a lot and was in intense pain and not able to sleep from the pain.  If I try not to use my arm, the pain is managable.  If I use my arm for daily tasks a lot the pain is intense.
High fever 104.1 Cough Congestion Fatigue Tested negative for Covid and flu
5OCT92 330PM t102 oral, pt limp & lethargic-mom gave APAP & pediaprofin; 6OCT92 pt screamed & made choking sound, limbs began jerking, neck & back arched episode lasted 10 minutes; pt vomited & lost consciousness for several minutes; t105;
Around 1:00 PM, I started having heart palpitations. I felt like my heart was skipping beats. Every time it happened, I felt like I had to gasp for breath. This was happening as often as every 2-3 minutes. This persisted throughout the night and into the next day on 9/29/2016. As of today, 9/30/2016, I am still having heart palpitations, just not as often.
SM went to PCP for evaluation of HA, body aches, general malaise and diarrhea she developed after being vaccinated with SPV, anthrax and typhoid.  After 2 days of using PERCOCET, still having pain in L arm where SPV was given.  SM placed on 2 days of quarters by PCP.  Given PT profile and light duty by VHC. Recommend use of ibuprofen and cold compresses to SPV site.  Erythema Start: 11/05/2007; Swelling Start: 11/05/2007; Tenderness Start: 11/05/2007; Pain Start: 11/05/2007
Covid-19 Bivalent booster given instead of Moderna Covid-19 Vaccine for first dose in primary series.
VACCINE GAVE ALMOST ALL THE  REACTIONS; EVERYTHING HURT; This spontaneous report received from a patient concerned a 43 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 09-JUL-2021 for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On 09-JUL-2021, the subject experienced vaccine gave almost all the reactions. On 09-JUL-2021, the subject experienced everything hurt. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the vaccine gave almost all the reactions and everything hurt was not reported. This report was non-serious.
Anaphylaxis event; Case reference number US-BN-2023-000328 is a spontaneous case report initially received from a consumer on 22-Feb-2023 and concerns a patient of unknown age and gender.  The patient's relevant medical history and concomitant medication details were not provided.  On an unspecified date, the patient was vaccinated with a dose of the rabies vaccine (rabies virus (inactivated, strain flury LEP); (batch number: not provided)) at an unknown dose, site, or route of administration for post-exposure rabies immunization. The reporter could not advise whether the patient received RabAvert or Imovax.   On an unspecified date, an unknown amount of time after the rabies vaccine, the patient experienced an anaphylaxis event.  At the time of this report, the outcome of the event was unknown.  The reporter did not provide a seriousness or causality assessment for the event. Additionally, the event of 'anaphylaxis' was assessed as serious, due to medically significance.   No further information was provided.; Reporter's Comments: A patient of unknown age and gender was vaccinated with a dose of an unspecified rabies vaccine, at an unknown dose, site, or route of administration for post-exposure rabies immunization. On an unspecified date, an unknown amount of time after the rabies vaccine, the patient experienced a serious event of anaphylaxis (medical significance). Anaphylactic reaction is listed for rabies vaccine according to the insert. The patient's relevant medical history and concomitant medication details were not provided. The outcome of the event was unknown. Since the evaluation did not find enough evidence to completely exclude a contributory role of the suspect vaccine to the development of the event, the anaphylactic reaction has been considered as related to rabies vaccine. This case is considered as serious due to medical significance.; Sender's Comments: A patient of unknown age and gender was vaccinated with a dose of an unspecified rabies vaccine, at an unknown dose, site, or route of administration for post-exposure rabies immunization. On an unspecified date, an unknown amount of time after the rabies vaccine, the patient experienced a serious event of anaphylaxis (medical significance). Anaphylactic reaction is listed for rabies vaccine according to the insert. The patient's relevant medical history and concomitant medication details were not provided. The outcome of the event was unknown. Since the evaluation did not find enough evidence to completely exclude a contributory role of the suspect vaccine to the development of the event, the anaphylactic reaction has been considered as related to rabies vaccine. This case is considered as serious due to medical significance.
8 y/o female developed a 2-3 cm erythematous patch, with a 1 cm bruise at the center, to right upper arm at the injection site 5-10 minutes after receiving Pfizer vaccine. Pt denies pain, itching, and all symptoms of respiratory distress. Pt was coloring with sibling and answering all of my questions. Ice pack applied with some improvement. Parent felt comfortable leaving site after 30 minutes. Instructed to go to ER/PCP if any new or worsening symptoms
After immunization had a red mark of about dime size per mom, this continued to grow and when I saw it 2 days later the area was erythematous, indurated and hot, very tender to touch. Erythema measuring around 10cm in the office.  No pus was able to be expelled.  Imms given in this leg were the PCV13 and Pedvax Hib.  Seen in clinic, child given Keflex and will f/u via phone.
DTap given 09/01/2005 that evening developed red welt around injection and low grade temp. Seen 09/07/2005 with 3 x 6 cm red, hot area around inj. No fever on Tylenol.
This spontaneous report as received from a physician refers to a 19 year old male patient. On an unknown date the patient was vaccinated with (Oka/Merck) PROQUAD, 0.5 ml subcutaneous (dose number, anatomical location and expiration date were not reported) when the patient was supposed to receive (Oka/Merck) VARIVAX and M-M-R II separately. No adverse effects reported. Concomitant therapies were unspecified. Additional information is not expected because reporter refused additional information.
Narrative: COVID infection following COVID vaccine series 03/27, Pfizer, dose #1 04/16, Pfizer, dose #2 12/24 COVID swab, result: detected 12/24 pt cc: chills, cough, diarrhea, fatigue, headache, nausea, rhinorrhea, sore throat exposure: unknown 12/24 CXR impression: No acute cardiopulmonary disease. 12/24 SARS-COV-2 Variant Sequencing: pending 12/24 pt admit ED cc: covid sx dx: Covid-19 LOS: I day 12/29 clinically resolved
I started have an increased number of episodes of Afib with a rapid ventricular response. My diastolic function has also increased from a level one to a level two and there is thickening in the walls of my heart. I ended up having a cardiac ablation and there was a complication, and I had an epigastric artery burst and that led to a massive abdominal bleed when I was in recovery, and I went into an emergency surgery to stop the bleeding.
Swollen lymph nodes in left armpit and collar bone. Muscle aches especially of upper body. Fatigue. Fever. Headache. Sore left arm. Itchiness at injection site.
On December 10, 2021 (over a month from vaccination on 11/3/2021) I had a 3-hour episode of Transient Global Amnesia, as diagnosed by the Medical Center ER and subsequent  visits.  I was functioning on some level (e.g. could walk, talk, etc.) but was unable to utilize short term memory.  My 34-year-old daughter was staying with us and discovered this situation, taking me to the ER.   I recovered after about 3 hours.  I don't remember anything in that period.  Note that I had the 2 dose regimen of Moderna vaccines in early 2021.  This 11-3-21 dose was apparently the 50% Moderna booster.
Initial case received from a consumer, who is also the patient, on 28 July 2011. A 41-year-old female patient, with a history of allergies to penicillin and sulfa, received injections of IMOVAX Rabies and IMOGAM Rabies-HT (lot numbers unknown) on 26 July 2011. The evening of vaccination, the patient developed muscle aches everywhere and numbness on the right side of her face. The day following vaccination, the facial numbness was "slightly improved" and muscle aches had decreased. She reported that she had seen a neurologist on 28 July 2011 due to her symptoms; outcome of the visit was not reported. At the time of the report, the events were still ongoing. Follow-up information received from a physician on 25 August 2011. The reporter only spoke with the patient on the phone and they had no other information to provide for the case. No other information for other contacts were provided. Follow-up information was received from a health care professional on 06 September 2011 reported that the reported did not administer the vaccine and there was no additional information to provide. Documents held by sender: None.
This spontaneous report as received from a consumer's sister refers to a female patient of unknown age. The reporter mentioned that her sister developed reactions to other company's products (unspecified). Other pertinent medical history was not reported. On an unknown date the patient was vaccinated with ZOSTAVAX 19400 PFU, (dose, dose number, route, anatomical location and expiration date were unspecified). No concomitant therapies were reported. On an unknown date the patient experienced chicken pox. The outcome of chicken pox was unknown. The relatedness between chicken pox and ZOSTAVAX was not reported. Additional information has been requested.
swollen arm, area very red and hot, rash, itching, pain. Was treated with benadryl, prelone, tylenol, ibuprofen, and a ice pack.
Refrigerated vaccine was administered 2 days after the Beyond Use Date.  Beyond Use Date was 11/01/2023.  Vaccine administered on 11/03/2023.
Information has been received from a certified medical assistant concerning a 44 year old female with no medical history and no known allergies who on 28-NOV-2006 was vaccinated with Pneumovax 23 (0.5 ml) (lot # 651437/0899F), in the left deltoid. Concomitant therapy that day included influenza virus vaccine, in the left deltoid, but different site, and a tetanus toxoid, in the right arm. On 30-NOV-2006 the patient experienced painful, swollen and red injection site from deltoid around to the armpit of the same arm. On 01-DEC-2006 the patient took over the counter antihistamines. The patient was instructed to take BENADRYL. The patient recovered. Additional information is not expected.
Treatment of COVID-19; Treatment of COVID-19; Moderna: Dose number: 1 and 2; Pfizer / BioNTech - Dose number: 3 and 4; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 29-year-old female patient (not pregnant) received BNT162B2, BNT162B2 OMI BA.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 22Sep2022 as dose 4 (booster), single (Lot number: GH9694) at the age of 29 years, in left arm for COVID-19 immunisation; BNT162b2 (BNT162B2), on 18Nov2021 as dose 3 (booster), single (Lot number: 30155BA) for COVID-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 06Mar2021 as dose 1, single (Lot number: 029A21A) and on 03Apr2021 as dose 2, single (Lot number: 026B21A) for COVID-19 immunisation. The patient's relevant medical history included: "anxiety" (unspecified if ongoing); "OCD" (unspecified if ongoing). Concomitant medication(s) included: ACETAMINOPHEN, start date:03Oct2022, stop date: 04Oct2022; IBUPROFEN, start date: 04Oct2022, stop date: 06Oct2022; OMEGA 3 [DOCOSAHEXAENOIC ACID;EICOSAPENTAENOIC ACID;TOCOPHEROL], start date: 04Oct2022, stop date: 11Oct2022. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19"; INTERCHANGE OF VACCINE PRODUCTS (medically significant), outcome "unknown", described as "Moderna: Dose number: 1 and 2; Pfizer / BioNTech - Dose number: 3 and 4". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Negative; Positive, notes: new positive test result occurred on Day 9; Positive, notes: tested positive on Day 5; Negative, notes: negative on Day 7; Positive, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, COVID-19.  Additional information: the patient was reported to have experienced a scratchy throat a day after a negative COVID test and several days after the cessation of symptoms and completion of a 5-day PAXLOVID course of treatment. She took a COVID test after the scratchy throat didn't resolve and received a positive result. This new positive test result occurred on Day 9 (with Day 1 being the first full day with symptoms and a positive COVID test result). She also tested positive on Day 5 and negative on Day 7. Her symptoms had mostly resolved by Days 3-4, though she still experienced fatigue.
Severe chest pain, debilitating pain in all joints from shoulders to ankles, swollen fingers on both hands, pin/needles sensation both hands, swelling on left side more pronounced than right side, left ear pain, tightness upper/lower jaw.  Adverse issues consistent and affecting activities of daily living.
This spontaneous report as received from a healthcare worker refers to a patient of unknown age and gender. On an unknown date the patient was vaccinated with improperly stored VARIVAX (lot number and expiry date unknown) (dosing regimen and frequency unknown). No concomitant medications were reported. No adverse effects were reported. It was reported that the VARIVAX underwent multiple supported temperature excursions. The action taken with the therapy with VARIVAX was unknown. The outcome of the events was unknown. The relatedness of the events to the therapy with VARIVAX was unknown. There was no product quality complaint reported. This is one of the many reports from the same source.
back pains; back spasms; This is a spontaneous report from a contactable physician.  A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on 21Dec2020 as a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. It was not reported if the patient was pregnant nor if any other vaccines were received 4 weeks prior to the vaccination. The patient reported that she had the COVID-19  vaccine last Monday (22Dec2020) and was told to stop taking NSAIDS. Now, she is experiencing back pains, so she wants to know when she could restart taking NSAIDs. She doesn't think her back spasms are from the COVID-19 vaccine. The clinical outcome of the back pains and back spasms was not reported. It was also not reported if the patient had been tested for COVID-19.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
chills; Body aches; fever; This is a spontaneous report from a contactable healthcare professional (HCP) reporting for herself. The 29-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number EL3247, expiry date unknown) on 17Jan2021 15:30 at single dose via an unspecified route of administration in the left arm for COVID-19 immunization. The patient's medical history was not reported. She had received her first dose of BNT162B2 (lot number ECO140, expiry date unknown) on 29Dec2020 at single dose via an unspecified route of administration in the left arm for COVID-19 immunization. She had not had COVID prior to the vaccination, not tested post the vaccination. She had no known allergies. Concomitant medication included escitalopram oxalate (LEXAPRO), cetirizine hydrochloride (ZYRTEC), ethinylestradiol/etonogestrel (NUVARING). No other vaccine received in four weeks. The patient experienced body aches, fever and chills on 18Jan2021 09:00. No seriousness criterion reported. No treatment for events was received. The events were resolved on an unspecified date in Jan2021.
Onset of hives at 10:33 am, monitored pt for 30 min, hives went away, pt discharged with parent.
Patient came to complain of ongoing pain from PREVNAR injection on 10/8/18. She complained of normal soreness at injection site day after injection. Self-treated with ice but soreness continued. She states that the pain radiated to the shoulder and up to the neck. She says that applying ice helps but that the problem has not gone away. She came into the grocery store to shop and decided to notify the pharmacy on 11/12/18. She says she will follow up with her primary care physician. This was the first time we were told of her pain. She is not completely sure that the pain in shoulder and neck are a result of the vaccine, but the symptoms started after receiving the vaccination.
Left sided throbbing of head, neck, and arm the evening of 2/10/21 with pain and ringing in left ear beginning same evening. Ringing in ear continues to this day. Saw Dr. on 3/12/21 and he confirmed tinnitus was caused by vaccine.
SHINGLES RASH; FEVER; CHILLS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805022,expiry: UNKNOWN) dose was not reported, administered on 11-MAR-2021 17:15 for prophylactic vaccination. No concomitant medications were reported. On 12-MAR-2021, the subject experienced fever. On 12-MAR-2021, the subject experienced chills. On 14-MAR-2021, the subject experienced shingles rash. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever on -MAR-2021, and chills on 12-MAR-2021, and had not recovered from shingles rash. This report was non-serious.
PROJECTILE VOMITING STARTED AND CONTINUED THRU EARLY MORNING. FEVER OF 100.
patient was 17; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (patient was 17) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044b21a and 033c21a) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (patient was 17). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (patient was 17) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.  No concomitant medications were reported.
Death Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was 80 and discharged on 2/17/21 with hospice after falling and suffering a subdural hematoma. Patient was likely reaching end of life from metastatic prostate cancer before fall.
Employee received H1N1 vaccine and shortly after receiving it started feeling tingling in face, hands, and feet. Also had dizziness with lightheadedness. Employee had some chest pressure and cool and clammy. Employee took one of her own BENADRYL of her own accord and started feeling much better, with most of the symptoms subsiding. Center Physician checked employee out with a thorough examination.
Pulmonary embolism -  Pt was initiated on coumadin w/ lovenox bridging. This is due to hx of brain bleed and need for readily reversible anticoagulant.  With assistance from the clinical pharmacist the pt was arranged for outpatient INR checks and follow up at a coumadin clinic in city. He was taught to self inject lovenox and given a 10 day supply to make sure he has enough supply in case the bridging takes longer. ED visit and hospital admission within 6 weeks of receiving the COVID vaccine.
Vomiting-slept until 7:30 AM, now feels weak and sore